The abstract is read at the publisher; the summary is JClub's.
Cellular and molecular imaging is positioned to enable new, personalized risk assessment in coronary artery disease by visualizing inflammatory and other atherosclerosis activity beyond structural burden.
- Why it matters: Coronary artery disease remains the dominant cause of death in many parts of the world, and residual risk linked to inflammation needs better in vivo markers for adverse outcomes.
- What they did: The review synthesizes advances in non-invasive and invasive structural imaging plus molecular imaging agents and hardware, integrating molecular signals with anatomical measures to study progression and treatment effects.
- The result: By combining cellular/molecular and anatomical readouts, the field supports improved understanding of disease progression, patient-specific risk, and intervention actions, with potential to guide therapy validation and dosing.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.